OPNT Annual Total Long Term Liabilities
$16.74 M
-$1.96 M-10.47%
31 December 2021
Summary:
As of February 5, 2025, OPNT annual total long term liabilities is $16.74 million, with the most recent change of -$1.96 million (-10.47%) on December 31, 2021. During the last 3 years, it has risen by +$14.04 million (+520.09%).OPNT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Quarterly Long Term Liabilities
$14.41 M
+$174.30 K+1.22%
30 September 2022
Summary:
As of February 5, 2025, OPNT quarterly total long term liabilities is $14.41 million, with the most recent change of +$174.30 thousand (+1.22%) on September 30, 2022. Over the past year, it has dropped by -$5.21 million (-26.57%).OPNT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.5% | -26.6% |
| 3 y3 years | +520.1% | +3924.5% |
| 5 y5 years | +691.3% | +499.8% |
OPNT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -10.5% | -26.6% |
Opiant Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $14.41 M(+1.2%) |
| June 2022 | - | $14.23 M(-0.2%) |
| Mar 2022 | - | $14.27 M(-14.8%) |
| Dec 2021 | $16.74 M(-10.5%) | $16.74 M(-14.7%) |
| Sept 2021 | - | $19.62 M(+0.0%) |
| June 2021 | - | $19.62 M(+4.5%) |
| Mar 2021 | - | $18.77 M(+0.4%) |
| Dec 2020 | $18.70 M(+7242.2%) | $18.70 M(>+9900.0%) |
| Sept 2020 | - | $0.00(-100.0%) |
| June 2020 | - | $34.80 K(-73.4%) |
| Mar 2020 | - | $131.00 K(-48.6%) |
| Dec 2019 | $254.70 K(-90.6%) | $254.70 K(-28.9%) |
| Sept 2019 | - | $358.00 K(>+9900.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(-100.0%) |
| Dec 2018 | $2.70 M(+27.6%) | $2.70 M(+571.6%) |
| Sept 2018 | - | $402.00 K(-80.7%) |
| June 2018 | - | $2.08 M(-3.7%) |
| Mar 2018 | - | $2.16 M(-9.9%) |
| Dec 2017 | $2.12 M(-8.3%) | - |
| Oct 2017 | - | $2.40 M(+4.1%) |
| July 2017 | $2.31 M(-1.9%) | $2.31 M(-3.4%) |
| Apr 2017 | - | $2.39 M(+29.0%) |
| Jan 2017 | - | $1.85 M(-21.3%) |
| Oct 2016 | - | $2.35 M(0.0%) |
| July 2016 | $2.35 M(-55.7%) | $2.35 M(+12.8%) |
| Apr 2016 | - | $2.08 M(-10.7%) |
| Jan 2016 | - | $2.33 M(-60.6%) |
| Oct 2015 | - | $5.92 M(+11.7%) |
| July 2015 | $5.30 M | $5.30 M(-8.6%) |
| Apr 2015 | - | $5.80 M(+20.5%) |
| Jan 2015 | - | $4.81 M(+46.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2014 | - | $3.28 M(+132.3%) |
| July 2014 | $1.41 M(+88.2%) | $1.41 M(+40.7%) |
| Apr 2014 | - | $1.00 M(0.0%) |
| Jan 2014 | - | $1.00 M(+33.8%) |
| Oct 2013 | - | $750.00 K(0.0%) |
| July 2013 | $750.00 K(>+9900.0%) | $750.00 K(+308.5%) |
| Apr 2013 | - | $183.60 K(-30.1%) |
| Jan 2013 | - | $262.80 K(>+9900.0%) |
| Oct 2012 | - | $0.00(0.0%) |
| July 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2012 | - | $0.00(0.0%) |
| Jan 2012 | - | $0.00(0.0%) |
| Oct 2011 | - | $0.00(0.0%) |
| July 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Apr 2011 | - | $0.00(0.0%) |
| Jan 2011 | - | $0.00(0.0%) |
| Oct 2010 | - | $0.00(-100.0%) |
| July 2010 | $380.60 K(>+9900.0%) | $380.60 K(>+9900.0%) |
| Apr 2010 | - | $0.00(0.0%) |
| Jan 2010 | - | $0.00(0.0%) |
| Oct 2009 | - | $0.00(0.0%) |
| July 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2009 | - | $0.00(0.0%) |
| Jan 2009 | - | $0.00(0.0%) |
| Oct 2008 | - | $0.00(0.0%) |
| July 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2008 | - | $0.00(0.0%) |
| Jan 2008 | - | $0.00(0.0%) |
| Oct 2007 | - | $0.00(0.0%) |
| July 2007 | $0.00 | $0.00(0.0%) |
| Apr 2007 | - | $0.00(0.0%) |
| Jan 2007 | - | $0.00 |
FAQ
- What is Opiant Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Opiant Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Opiant Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of OPNT is $16.74 M
What is the all time high annual total long term liabilities for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual total long term liabilities is $18.70 M
What is Opiant Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, OPNT annual total long term liabilities has changed by -$1.96 M (-10.47%)
What is Opiant Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of OPNT is $14.41 M
What is the all time high quarterly long term liabilities for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly total long term liabilities is $19.62 M
What is Opiant Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, OPNT quarterly total long term liabilities has changed by -$5.21 M (-26.57%)